Latest News

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – February 14, 2025

February 14th 2025

Review top news and interview highlights from the week ending February 14, 2025.

No Significant Reduction of CRS or ICANS Seen With Sobi's Anakinra in Patient's Receiving Liso-Cel for LBCL
No Significant Reduction of CRS or ICANS Seen With Sobi's Anakinra in Patient's Receiving Liso-Cel for LBCL

February 14th 2025

Reena Sharma, MD, an adult metabolic consultant at Salford Royal Hospital
Reena Sharma, MD, on Assessing Spur Therapeutics’ Gene Therapy FLT201 in Gaucher Disease

February 13th 2025

CareDx’s AlloHeme Shows Accuracy in Detecting Relapse Following AlloHSCT in AML and MDS
CareDx’s AlloHeme Shows Accuracy in Detecting Relapse Following AlloHSCT in AML and MDS

February 13th 2025

Phase 2 Trial for BMS's Liso-Cel Meets Primary End Point in R/R Marginal Zone Lymphoma Cohort
Phase 2 Trial for BMS's Liso-Cel Meets Primary End Point in R/R Marginal Zone Lymphoma Cohort

February 12th 2025

Video Interviews

Conference Coverage

View All
No Significant Reduction of CRS or ICANS Seen With Sobi's Anakinra in Patient's Receiving Liso-Cel for LBCL
No Significant Reduction of CRS or ICANS Seen With Sobi's Anakinra in Patient's Receiving Liso-Cel for LBCL

February 14th 2025

Reena Sharma, MD, an adult metabolic consultant at Salford Royal Hospital
Reena Sharma, MD, on Assessing Spur Therapeutics’ Gene Therapy FLT201 in Gaucher Disease

February 13th 2025

Mark Hamilton, MD, PhD, a hematology-oncology and bone marrow transplant (BMT) cell therapy fellow at Stanford University
Analyzing PostCAR Myeloid Neoplasms

February 7th 2025

Mark Hamilton, MD, PhD, a hematology-oncology and bone marrow transplant (BMT) cell therapy fellow at Stanford University
Mark Hamilton, MD, PhD, on Analyzing PostCAR Myeloid Neoplasms

February 5th 2025

All News

© 2025 MJH Life Sciences

All rights reserved.